Can we predict who's at risk for developing bone metastases in breast cancer?
J. Clin. Oncol., Sep;29(27):3600-4 (2011)
Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour.
J. Med. Genet., Jul;48(7):473-6 (2011)
Are bisphosphonates ready for the adjuvant setting?
Oncology (Williston Park, N.Y.)., May;24(6):480, 485 (2010)
No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.
Breast Cancer Res. Treat., Jan;125(1):169-73 (2011)
Multidisciplinary meeting on male breast cancer: summary and research recommendations.
J. Clin. Oncol., Apr;28(12):2114-22 (2010)
Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype.
Endocr. Relat. Cancer., Jun;17(2):R109-21 (2010)
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer.
Breast Cancer Res. Treat., Feb;119(3):685-99 (2010)
A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome.
Cancer Epidemiol., Jul;33(1):31-6 (2009)
Cancer risk assessment for the primary care physician.
Prim. Care., Sep;36(3):471-88 (2009)
Recruitment to a physical activity intervention study in women at increased risk of breast cancer.
BMC Med Res Methodol., 9:27 (2009)
Childhood soy intake and breast cancer risk in Asian American women.
Cancer Epidemiol. Biomarkers Prev., Apr;18(4):1050-9 (2009)
Assessing breast cancer risk: genetic factors are not the whole story.
Postgrad Med., Oct;116(4):6-8, 11-4, 19-20 (2004)